New treatment tested for rare nerve diseases in japan

NCT ID NCT05084053

Summary

This study is testing a drug called TAK-771 to see if it can safely control symptoms in Japanese adults with two rare, long-term nerve disorders: CIDP and MMN. Participants, who must already be responding to a standard treatment, will receive TAK-771 for up to 45 months. The main goals are to see if the drug prevents symptom flare-ups and improves strength and daily function.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY (CIDP) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Aichi Medical University Hospital

    Nagakute, Aichi-ken, Japan

  • Asahikawa Medical Center

    Asahikawa, Hokkaido, Japan

  • Chiba University Hospital

    Chiba, Chiba, Japan

  • Chubu Rosai Hospital

    Nagoya, Aichi-ken, Japan

  • Fujita Health University Hospital

    Toyoake, Aichi-ken, Japan

  • Higashimatsuyama Municipal Hospital

    Higashi-Matsuyama, Saitama, Japan

  • Hiroshima University Hospital

    Hiroshima, Hiroshima, Japan

  • Hyogo College of Medicine Hospital

    Nishinomiya, Hyōgo, Japan

  • Juntendo University Hospital

    Bunkyo-ku, Tokyo, Japan

  • Kansai Rosai Hospital

    Amagasaki, Hyōgo, Japan

  • Kumamoto University Hospital

    Kumamoto, Kumamoto, Japan

  • Kyushu University Hospital

    Fukuoka, Fukuoka, Japan

  • Nara Medical University Hospital

    Kashihara, Nara, Japan

  • National Center of Neurology and Psychiatry

    Kodaira, Tokyo, Japan

  • Shiga University of Medical Science Hospital

    Ōtsu, Shiga, Japan

  • St.Marianna University School of Medicine Hospital

    Kawasaki, Kanagawa, Japan

  • Toho University Omori Medical Center

    Ōta-ku, Tokyo, Japan

  • Tohoku Medical and Pharmaceutical University Hospital

    Sendai, Miyagi, Japan

  • Tokushima National Hospital

    Yoshinogawa, Tokushima, Japan

  • Tokushima University Hospital

    Tokushima, Tokushima, Japan

  • Tokyo Women's Medical University Hospital

    Shinjuku-ku, Tokyo, Japan

  • Toyama University Hospital

    Toyama, Toyama, Japan

  • Yamaguchi University Hospital

    Ube, Yamaguchi, Japan

Conditions

Explore the condition pages connected to this study.